Literature DB >> 16374524

A mouse prostate cancer model induced by Hedgehog overexpression.

Bo-Yie Chen1, David Pei-Cheng Lin, Jer-Yuh Liu, Han Chang, Po-Hsuan Huang, Yie-Ling Chen, Han-Hsin Chang.   

Abstract

Hedgehog is a regulatory protein during embryonic development and its abnormal activation in adult tissues has been implicated in tumorigenesis within sites where epithelial-mesenchymal interactions take place. In the prostate, Hedgehog signaling activation was observed during advanced cancer progression and metastasis, but whether Hedgehog overexpression can initiate prostate tumorigenesis remains unknown. We introduced a Hedgehog-expressing vector by intra-prostate injection and electroporation to address the effects of Hedgehog overexpression. The manipulation caused lesions with characteristic prostatic intraepithelial neoplasia or even prostatic cancer (CaP) phenotypes within 30 days, with Hedgehog overexpression demonstrated by immunohistochemistry and Western blot detections. The tumorigenic phenotypes were confirmed by discontinuity of basal cell marker p63, mix-up of CK-8/CK-18 positive epithelial cells in the stoma as well as absence of alpha-SMA positive fibro-muscular sheath. Comparable Hedgehog overexpression was found in human CaP specimen. Thus, Hedgehog overexpression induced prostate tumorigenesis starting from the normal status. Furthermore, a mouse prostate cancer model induced by Hedgehog overexpression was established and may be used for testing novel therapeutical approaches targeting at Hedgehog signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16374524     DOI: 10.1007/s11373-005-9050-x

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  16 in total

Review 1.  Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Anticancer Agents Med Chem       Date:  2010-02       Impact factor: 2.505

2.  The hedgehog/Gli signaling paradigm in prostate cancer.

Authors:  Mengqian Chen; Richard Carkner; Ralph Buttyan
Journal:  Expert Rev Endocrinol Metab       Date:  2011

Review 3.  Animal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2011-03-17

Review 4.  Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

5.  Congenital eye malformations associated with extensive periocular neural crest apoptosis after influenza B virus infection during early embryogenesis.

Authors:  Bo-Yie Chen; Han-Hsin Chang; Shyan-Tang Chen; Zih-Jay Tsao; Shang-Min Yeh; Chia-Yung Wu; David Pei-Cheng Lin
Journal:  Mol Vis       Date:  2009-12-19       Impact factor: 2.367

Review 6.  Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.

Authors:  Murielle Mimeault; Parmender P Mehta; Ralph Hauke; Surinder K Batra
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

Review 7.  Prostate cancer and Hedgehog signalling pathway.

Authors:  L M Antón Aparicio; R García Campelo; J Cassinello Espinosa; M Valladares Ayerbes; M Reboredo López; S Díaz Prado; G Aparicio Gallego
Journal:  Clin Transl Oncol       Date:  2007-07       Impact factor: 3.405

Review 8.  Hedgehog signaling in mammary gland development and breast cancer.

Authors:  Sarah Hatsell; Andra R Frost
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-09       Impact factor: 2.673

9.  Dietary zerumbone prevents mouse cornea from UVB-induced photokeratitis through inhibition of NF-κB, iNOS, and TNF-α expression and reduction of MDA accumulation.

Authors:  Bo-Yie Chen; David Pei-Cheng Lin; Chia-Yung Wu; Mei-Ching Teng; Chi-Yun Sun; Yuan-Ting Tsai; Kuo-Chen Su; Soo-Ray Wang; Han-Hsin Chang
Journal:  Mol Vis       Date:  2011-04-06       Impact factor: 2.367

10.  SHH-N non-canonically sustains androgen receptor activity in androgen-independent prostate cancer cells.

Authors:  Diana Trnski; Maja Sabol; Sanja Tomić; Ivan Štefanac; Milanka Mrčela; Vesna Musani; Nikolina Rinčić; Matea Kurtović; Tina Petrić; Sonja Levanat; Petar Ozretić
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.